{
    "Trade/Device Name(s)": [
        "On Call Sharp Blood Glucose Monitoring System",
        "On Call Sharp Blood Glucose Meter",
        "On Call Sharp Blood Glucose Test Strips",
        "On Call Sharp Glucose Control Solution"
    ],
    "Submitter Information": "ACON Laboratories, Inc.",
    "510(k) Number": "K130284",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112653"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "December 20, 2013",
    "Summary Letter Received Date": "December 18, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single analyte control"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "On Call Sharp Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "FAD-dependent glucose dehydrogenase biosensor"
    ],
    "Methodologies": [
        "Quantitative glucose measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for On Call Sharp Blood Glucose Monitoring System for home glucose quantification using amperometric detection.",
    "Indications for Use Summary": "Intended for the quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, and palm by people with diabetes at home to aid in monitoring diabetes control; for single patient use, not for diagnosis or screening or for use on neonates.",
    "fda_folder": "Clinical Chemistry"
}